Abstract Chronic cerebral hypoperfusion (CCH) evokes mild cognitive impairment (MCI) and contributes to the progression of vascular dementia and Alzheimer's disease (AD). How CCH induces these neurodegenerative processes that may spread along the synaptic network and whether they are detectable at the synaptic proteome level of the cerebral cortex remains to be established. In the present study, we report the synaptic protein changes in the cerebral cortex after stepwise bilateral common carotid artery occlusion (BCCAO) induced CCH in the rat. The occlusions were confirmed with magnetic resonance angiography 5 weeks after the surgery. Synaptosome fractions were prepared using sucrose gradient centrifugation from cerebral cortex dissected 7 weeks after the occlusion. The synaptic protein differences between the sham operated and CCH groups were analyzed with label-free nanoUHPLC-MS/MS. We identified 46 proteins showing altered abundance due to CCH. In particular, synaptic protein and lipid metabolism, as well as GABA shunt-related proteins showed increased while neurotransmission and synaptic assembly-related proteins showed decreased protein level changes in CCH rats. Protein network analysis of CCHinduced protein alterations suggested the importance of increased synaptic apolipoprotein E (APOE) level as a consequence of CCH. Therefore, the change in APOE level was confirmed with Western blotting. The identified synaptic protein changes would precede the onset of dementia-like symptoms in the CCH model, suggesting their importance in the development of vascular dementia.
Introduction
Chronic cerebral hypoperfusion (CCH) is relatively common in the elderly and it is a major contributor to cerebrovascular dementia [1, 2] and also an important risk factor for Alzheimer's disease (AD) [3] . However, the molecular background how CCH causes cognitive impairment and how it Katalin Völgyi and Péter Gulyássy contributed equally to this work.
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* Katalin Völgyi katvolgyi@gmail.com contributes to Alzheimer's pathogenesis is poorly understood, even though a deeper understanding of the molecular process would be essential for developing new therapeutic strategies to prevent the progression of CCH towards AD. CCH can be detected in mild cognitive impairment prior to dementia using different imaging techniques [4] . CCH causes capillary degeneration, which reduces the diffusion of nutrition and oxygen supply to brain cells resulting in the degeneration of the nerve tissue. The onset of CCH is in the associative cortical areas; then, it spreads throughout the brain via the neuronal network, affecting large parietal and temporal cortical areas [5] . Synapse loss is an early feature of AD which correlates with the severity of dementia [6] .
Bilateral common carotid artery occlusion (BCCAO)-induced CCH is a widely used model of vascular dementia [7, 8] . For better survival rate and to avoid the acute ischemic stroke, we used a CCH model where BCCAO was induced with 1-week interval between occlusions of the left and right common carotid arteries [9] , which leads to a more gradual development of CCH in the brain [8] . The rat is a frequently used species of this model due to its good recovery rate from surgery, good reproducibility, and because the complete circle of Willis allows permanent carotid occlusion during a period of reduced blood flow after the onset of BCCAO. This animal model shows learning and memory impairments resembling those found in AD and vascular dementia, accompanied by neuronal degeneration, long-lasting white matter lesion, microglial activation, astrocytosis, and microvascular abnormalities [7, 10] . White matter damage is detectable with diffusion tensor imaging (DTI) at the early stages of brain injury following CCH [11] . In addition, cerebral hypoperfusion accelerates cerebral amyloid angiopathy [12] , enhances tau hyperphosphorylation, and upregulates β-amyloid precursor protein cleavage enzyme 1 (BACE1) and β-amyloid level in the brain [13] , the main neuropathological hallmarks of AD.
Although the underlying pathophysiological mechanisms and their consequences have been widely studied in the CCH model, unbiased proteomic studies are scarce and the molecular changes in CCH-affected brain are not well understood. Because CCH-induced neurodegeneration spreads along the neuronal networks, the aim of the present study was to describe the effect of CCH on the synaptic proteome of the rat cerebral cortex focusing on its possible role in the progression of AD.
Methods Animals
The care and experimentation of all animals conformed to the Hungarian Act of Animal Care and Experimentation (1998, XXVIII) and to the guidelines of the European Communities Council Directive, 86/609/EEC as well as with local regulations for the care and use of animals for research. Rats were kept under standard laboratory conditions (12-h light/dark cycle, lights on at 08.00 a.m. and off at 08.00 p.m.) with free access to food and water. Three-month-old male Harlan Wistar rats (weights of 310-390 g at the beginning of the experiments) were subjected to stepwise complete bilateral occlusion of the common carotid arteries (n = 6). Shamoperated rats without artery occlusion served as the control group (n = 6). For better survival rate and to avoid the ischemic lesions of the brain, the two common arteries were occluded with 1 week delay (stepwise BCCAO) and the shamoperated animals were also operated with this schedule.
Stepwise Occlusion of Common Carotid Arteries
Rats were anesthetized with isoflurane (1.5-2% in air) and a ventral midline incision was made on the neck. Common carotid arteries were exposed and gently separated from the vagus nerve, and the left carotid artery was occluded in the first step by three ligatures (2-0). One week later, a new incision was made and the right carotid was occluded as well in the second step. The sham-operated animals were also operated with this schedule; the same thread (2-0) was placed around the vessels without ligatures. After the procedure, rats were put back to their home cages and allowed to recover.
Magnetic Resonance Angiography
The occlusions were confirmed with magnetic resonance angiography (MRA). Five weeks after the second occlusion, anesthetized animals (isoflurane in air 1-1.5%) were scanned in a 9.4-T MRI system (Varian, Medical Systems Inc., Palo Alto, CA) with a free bore of 210 mm, containing a 120-mm inner size gradient coil. 3D time-of-flight (TOF) angiography (3D gradient echo) was performed with TR/TE = 30/2.8 ms, resolution = 0.42 × 0.42 × 0.46 mm.
Dissection of Cerebral Cortical Samples
The Wistar rats from both groups (n = 6-6) were anesthetized with isoflurane (1-1.5% in air) then decapitated and the brains were removed rapidly. The brains were washed in artificial cerebral spinal fluid (ACSF), the cerebral cortices were dissected, and the tissue samples were immediately frozen on dry ice and stored at −80°C until further studies.
Isolation of Synaptosomes from Rat Cerebral Cortical Samples
Synaptosomes were prepared by the method of Hahn et al. with minor modifications [14] . Briefly, the cerebral cortical tissue was homogenized using a Dounce-type glass homogenizer (Small Clearance, Kontes Glass Co.) with 40 strokes in 1 ml of homogenization buffer (320 mM sucrose, 0.1 mM CaCl 2 , 1 mM MgCl 2 ) supplemented with protease and phosphatase inhibitor cocktails (Sigma-Aldrich, St.Louis, MO, USA). To avoid postmortem degradation, all steps were performed on ice in a cold room. The homogenate was adjusted to 1.25 M sucrose and 0.1 mM CaCl 2 to a total volume of 5 ml and was transferred to a centrifuge tube. Five milliliters of 1 M sucrose solution was overlaid on it and centrifuged at 100,000×g for 3 h in an SW-40 rotor. The band at the interface was collected with a needle as the synaptosome fraction. To reduce the sucrose content of the fraction, the sample was diluted with 5 × 0.1 mM CaCl 2 and centrifuged at 15,000×g for 20 min. The pellet was precipitated with icecold acetone overnight. On the next day, the sample was spinned down, the acetone was removed, and the pellet was allowed to dry.
Electron Microscopy Validation of Synaptosome Samples
For the electron microscopic validation, synaptosome samples were performed as described before [15] . In brief, synaptosome fractions were fixed with 2% formaldehyde and 0.5% glutaraldehyde in 0.1 M Na-cacodylate for 30 min at room temperature. The samples were postfixed in 0.5% osmium tetroxide and 0.75% potassium hexacyano-ferrate for 45 min, dehydrated and embedded in LR White resin. A Jeol JEM 1011 electron microscope operating at 60 kV was used to examine the ultrathin sections. Images were taken with an Olympus Morada 11-megapixel camera and iTEM software (Olympus).
Processing of Synaptosomes for Proteome Analysis
The precipitated samples were taken up in lysis buffer (7 M urea, 2 M thiourea, 20 mM Tris, 5 mM Mg(Ac) 2 , 50 mM DTT) and were sonicated on ice until completely dissolved. The concentration was determined using the 2D Quant Kit (GE Healthcare, Little Chalfont, UK). The proteins were digested using the filter-aided sample preparation method published by Wisniewski et al. with minor modifications [16] . Briefly, 150 μg of the sample was diluted to a volume of 200 μl with urea buffer (8 M urea, 100 mM Tris-HCl pH 8.5) transferred to a Microcon YM-30 filter device (Merck, Germany) and spinned down at 14,000×g for 15 min at room temperature. Then, 200 μl urea buffer was added to the sample and spinned down again. To carbamidomethylate the proteins, 100 μl of IAA solution (50 mM iodoacetamide, 8 M urea, 100 mM Tris-HCl pH 8.5) was pipetted onto the filter and mixed at 450 rpm at room temperature for 3 min in a thermo-mixer, then incubated for 45 min at RT in dark without mixing and the sample was centrifuged for 10 min at the end. One hundred microliters of urea solution was added to the sample, spinned down for 15 min, and this step was repeated twice. Later, 100 μl of 50 mM NH 4 HCO 3 was added and the sample was centrifuged for 10 min, and this step was also repeated twice. The proteins were recovered from the filter by a reverse spin of 1500×g for 3 min and 100 μl of digestion solution (0.1% RapiGest, 50 mM NH 4 HCO 3 ) and trypsin (sequencing grade modified, Promega, Madison, WI, USA) were added in a 1:50 ratio. The sample was digested overnight at 37°C. The following day, the reaction was stopped by adding 4 μl of formic acid and the sample was desalted on a Pierce C-18 spin column (Thermo Scientific, Sunnyvale, CA, USA) according to the instruction of the supplier and dried in a speed-vac.
Protein Identification by NanoUHPLC-MS/MS
Liquid chromatography-mass spectrometry was performed using a Maxis II ETD QqTOF (Bruker Daltonics, Bremen, Germany) coupled to an Ultimate 3000 nanoRSLC system (Dionex, Sunnyvale, CA, USA) under the control of Hystar v.3.2 (Bruker Daltonics, Bremen, Germany). Samples were dissolved in 40 μl of 2% acetonitrile and 0.1% formic acid in water, out of which 5 μl were injected onto an Acclaim PepMap100 C-18 trap column (100 μm × 20 mm, Thermo Scientific, Sunnyvale, CA, USA). Sample desalting and preconcentration were performed with 0.1% trifluoracetic acid for 8 min with a flow rate of 5 μl/min. Peptides were separated on an ACQUITY UPLC M-Class Peptide BEH C18 column (130 Å, 1.7 μm, 75 μm × 250 mm, Waters, Milford, MA, USA) at 48°C using a flow rate of 300 nl/min. HPLC solvents were as follows: solvent A consisted of 0.1% formic acid in water and solvent B consisted of 0.1% formic acid in acetonitrile. The gradient was as follows: 4% B from 0 to 11 min, followed by a 120-min gradient to 50% B, then the concentration of the solvent B was elevated to 90% in 1 min and kept there for 10 min. After each sample, a blank was ran to a void carryover. Sample ionization was achieved in the positive electrospray ionization mode via a CaptiveSpray nanoBooster ion source. The capillary voltage was set to 1300 V, the nanoBooster pressure was 0.2 Bar, the drying gas was heated to 150°C, and the flow rate was 3 l/min. External mass calibration was done using the low concentration tuning mix from Agilent technologies via direct infusion. Internal mass calibration was performed via lock mass for each run using sodium formate. The ion transfer parameters were set as follows: prepulse storage 10 μs, collision transfer 10 μs, quadrupole ion energy 5 eV, Funnel 1 RF 400 Vpp, and Multipole RF 400 Vpp. The collision RF was set to 1200 Vpp and the ion transfer time was 120 μs. The MS spectra were recorded with a fix cycle time of 2.5 s over the mass range of m/z 150-2200 at 3 Hz with a minimal precursor mass of 322 m/z. The CID was performed at 16 Hz for abundant precursors and at 4 Hz for ones of low abundance. Singly charged peptides were excluded from the analysis; only multiple charged peptides were chosen for fragmentation. The collision energy for precursor signals was set automatically followed by the manufacturer's recommendations based on the isolation m/z, isolation mass range width, and charge state of the ion. An active exclusion of 2 min after one spectrum was used except if the intensity of the precursor was elevated threefold. For protein content analysis, raw data were recalibrated using the Compass DataAnalysis software 4.3 (Bruker Daltonics, Bremen, Germany). The samples were matched with the Rattus norvegicus SwissProt database using the Mascot server v.2.5 (Matrix Science, London, UK). The parameters for the Mascot search were set as follows: trypsin as the enzyme, and maximum two missed cleavages were allowed. Cysteine carbamidomethylation and methionin oxidation were used as fixed and variable modifications, respectively. Precursor mass tolerance was set to 7 ppm; the MS/MS mass tolerance was 0.05 Da. Decoy database was generated by Mascot and the false discovery rate was less than 1% in each search result. Proteins with a minimum of two identified, unique peptides were accepted. Label-free quantification was performed using MaxQuant software version 1.5.3.30. LC-MS/MS runs were aligned using the Bmatch between runs^feature (match time window 0.8 min, alignment time window 15 min). The following requirements were set: minimum peptide ratio count 2 and Bunique + razor^peptide for quantification. Only the peptides without modifications were taken into consideration in quantitative analysis.
Functional Clustering
Significantly altered proteins were clustered on the basis of the UniProt (http://www.uniprot.org/) and GeneOntology (http:// geneontology.org/) databases. The proteins showing increased or decreased expression levels were clustered separately in groups according to their most relevant cellular functions and roles in synaptic processes (Tables 1 and 2 ).
Bioinformatic Analysis of Significant Protein Changes
The bioinformatic pathway analysis to uncover the linkage between AD and the CCH-induced significantly altered cortical synaptic proteins was performed by Elsevier Pathway Studio Platform.
Western Blot
Among the mass spectrometry-identified CCH-induced significant protein changes, APOE was selected for WB validation as it is known to have a major role in Alzheimer's and cardiovascular diseases. For validation, the same samples were used which were utilized in the mass spectrometry analysis. Proteins were separated with Tricine-SDSpolyacrylamide gel electrophoresis on 10% polyacrylamide gels and transferred to Hybond-LFP PVDF membranes (GE Healthcare). The membranes were blocked with 5% BSA in Tris-buffered saline containing 0.1% Tween 20 (TBS-T). The membranes were incubated overnight in rabbit antiapolipoprotein E primary antibody (EPR19392) (Abcam, ab183597, 1:500 dilution) and mouse anti-synaptophysin (SY38) (monoclonal) primary antibody (Abcam, ab8049, 1:1500 dilution) dissolved in TBS-T. Subsequently, the membranes were washed for 4 × 5 min in TBS-T followed by the incubation with Cy5 and Cy3 CyDye conjugated anti-rabbit and mouse IgG secondary antibodies (1:2500 dilution, GE Healthcare). After, the washing steps in TBS-T and later in TBS the bands were visualized using a Typhoon TRIO+ scanner. Fluorescence intensities were quantified using the ImageQuant TL software. The densitometry data of protein band intensities were analyzed with the Image J software (NIH, Bethesda). Densitometric values of the APOE protein bands were normalized to the average densities of the synaptophysin (SYP) in the same sample. Differences between CCH and control synaptosome samples were statistically analyzed using independent Student's t test.
Results

Magnetic Resonance Angiography
Magnetic resonance angiography studies show that the blood flow in the carotid arteries were successfully blocked bilaterally in all CCH animals while it remained unaffected in the sham-operated control rats (Fig. 1) . The thickening of vertebro-basilar arteries was also observed in each CCH animal due to the BCCAO.
Validation of the Purity of the Synaptosome Preparation with Electron Microscope
Electron microscopic analysis revealed that the samples mostly consist of synaptosomes containing characteristic pre-and postsynaptic elements. Presynaptic endings contain synaptic vesicles and mitochondria. Postsynaptic elements were attached to most of the sealed presynaptic terminals. Nucleus-or cell body-related compartments (lysosomes and Golgi apparatus) were not present in the samples, suggesting the purity and enrichment of the synaptosome preparation (Fig. 2) .
Functional Clusters of Altered Proteins
In the present study, we identified (with at least 3 peptides) 23 proteins with significantly increased (Table 1 ) and 23 proteins with decreased (Table 2 ) expression level by more than ±1.3-fold change in CCH rats compared to sham-operated control animals (t test, P < 0.05). Fold changes of the altered proteins were in the range of −1.73 to +1.55. To graphically represent the significance and magnitude of protein changes, volcano plot-log10(P value) vs. log2(fold change of hypoperfusion / control group)-was constructed. Points above the non-axial horizontal line represent proteins with significantly different abundances (P < 0.05). Points to the left of the left nonaxial vertical line indicate protein fold changes of (Fig. 3) . The proteins showing increased expression levels participate in a variety of metabolic processes, including protein biosynthesis and folding (n = 6); ubiquitinmediated degradation (n = 4), lipid metabolism (n = 4), GABA shunt (n = 3), ion transport and homeostasis (n = 2), MAPK signaling pathway (n = 2), mitochondrial transport (n = 1), and nucleotide metabolism (n = 1) based on GeneOntology database. Expressions of protein biosynthesis and folding-related proteins changed to the greatest extent ( Table 1) . The proteins with decreased expression level after CCH participate in a variety of synaptic processes including synaptic vesicle cycle (n = 5), synaptic assembly (n = 3), GABAerg neurotransmission (n = 3), ion transport and homeostasis (n = 4), neurogenesis (n = 3), cell adhesion (n = 3), complement regulation (n = 1), and mitochondrial transport (n = 1). Expressions of synapse assembly and neurotransmission-related proteins decreased to the greatest extent. (Table 2) .
Western Blot
WB analysis was performed for APOE in the synaptosome fraction of the cerebral cortex (Fig. 4) . The protein expression of APOE (2.32 ± 0.78) showed a significant increasing level in the CCH synapse compared to the synapse from the shamoperated control rats (p < 0.05). Thus, the WB results of the APOE protein confirmed the LC-MS/MS data.
Discussion
Angiography of rats in our study represents a thorough control of the occlusion procedure. Indeed, blood supply by the carotid arteries was blocked in all animals. Blood supply to the brain by other routes including the visibly thickened vertebrobasilar artery compatible with the progressive process of vascular remodeling [17] . Our results indicate that these adaptations are accompanied by alteration of the synaptic protein content. The electron microscopic imaging demonstrated that our synaptosome preparation contained sealed presynaptic terminals and postsynaptic vacuoles with intact synaptic specialization, suggesting that the altered proteins are located in these The altered proteins belong to several functional categories. It is noteworthy that proteins belonging to the same functional category all increased or decreased their levels in CCH Fig. 3 Volcano plot illustrates magnitude and significance of the protein comparisons between the hypoperfusion and control groups. The −log10 (P value) is plotted against the log2 (fold change: hypoperfusion/control group). The non-axial vertical lines denote ±1.3-fold change while the non-axial horizontal line denotes P = 0.05 significance threshold (prior to logarithmic transformation). Significantly altered proteins with more than ±1.3-fold change are highlighted with gene names animals. This allows interpretation of changes of the particular functional processes in the synapse, rather than only individual proteins. Reduced synaptic vesicle cycle, synaptic assembly and ion transport, as well as the increased protein and lipid metabolism suggest a number of possible mechanisms of this transition (Fig. 5) .
Chronic Cerebral Hypoperfusion Effects on GABAergic/Glutamatergic Synaptic Communication
A number of synaptic transmission-related proteins showed decreased level in CCH rats. They participate both in the release and reuptake of amino acid neurotransmitters. Among them, three GABAergic/glutamatergic transmission-related proteins showed decreased protein level: Excitatory amino acid transporter 2 (SLC1A2), sodium-and chloridedependent GABA transporter 1 (SLC6A1) and gammaaminobutyric acid type B receptor subunit 2 (GABABR2). According to published electron microscopic studies, SLC1A2 is mainly present in astrocytic soma and processes surrounding capillaries and axon terminals mainly around glutamatergic synapses, consistent with its role in facilitating glutamate reuptake and limiting glutamate spillover [18] . SLC6A1 immunoreactivity is mainly present in axon terminals of symmetrical synapses in the cortex, suited for GABA recycling in the presynaptic terminals following a release event, which is essential to sustain GABAergic synaptic transmission [19] . Metabotropic GABA receptors are coupled to Immunopositive bands are shown at 36 kDa for APOE, and 38 kDa for SYP loading control. Densitometric analysis was performed for APOE (n = 6). The expression of APOE was significantly increased in the CCH synapse compared to the synapse from the sham operated control rats (*p < 0.05). Error bars indicate s.e.m second-messenger systems through G-proteins and mediate slow and prolonged inhibitory effects [20] . Electron microscopic studies showed that GABABR2 is more abundant on the postsynaptic than presynaptic side with a dominant extrasynaptic membrane localization. Moreover, besides its main GABAergic synaptic localization, it is also associated with putative glutamatergic synapses, suggesting its involvement in both GABAergic and glutamatergic neurotransmission [21] . Consistent with our results, GABABR2 showed decreased cell surface expression in the hippocampus of BCCAO rats, which showed significant cognitive impairment [22] .
Baclofen, a GABABR agonist, improved the downregulation of GABABR2 expression associated with cognitive impairment [22] and special working memory impairment [23] , while also reversed neuronal damage with autophagy regulation under chronic cerebral hypoperfusion [24] . Similar to our synaptic results, AP2-associated protein kinase 1 (AAK1) expression was significantly reduced in the hippocampal CA1 region under chronic cerebral hypoperfusion, which could be restored by baclofen to the control level [25] (Fig. 5) .
In the present study, three γ-aminobutiric acid (GABA) shunt-related proteins showed increasing protein level in the cortical synapse of CCH rats: pyridoxine-5-phosphate oxidase (PNPO), branched-chain-amino-acid aminotransferase, cytosolic (BCAT1), and aflatoxin B1 aldehyde reductase member 2 (ARK72) (or succinic semialdehyde reductase, SSAR) (Fig. 5) . PNPO catalyzes the oxidation of pyridoxine 5′-phosphate (PNP) into pyridoxal 5′-phosphate (PLP) which is an allosteric cofactor of BCAT1 and glutamate decarboxylase (GAD) enzymes [26] . BCAT1 is localized exclusively in neurons in the adult rat brain and catalyzes the reversible transamination of α-ketoglutarate to glutamate while GAD catalyzes the decarboxylation of glutamate to GABA [27] . GABA degradation has an important role in glutamate-and GABAerg balance and generates succinic semialdehyde (SSA) intermediate via the activation of GABA transaminase (GABA-T). SSA is normally converted to succinate through the activation of succinic semialdehyde dehydrogenase (SSADH). However, upon activation of ARK72, SSA is converted to GHB, as an alternative route from the GABA shunt [28] .
APOE-Mediated Synaptic Effects of Chronic Cerebral Hypoperfusion
APOE showed increased level in the synapse of CCH rats. It is indeed known to be released from neurons as the consequence of injury or stress [29] . The expression of APOE is significantly increased with AD compared to the control brain [30] . Furthermore, clinical studies revealed that AD patients have significantly lower APOE serum levels but higher cerebrospinal fluid levels compared to healthy [31, 32] . APOE4-positive AD individuals are often associated with impaired neurotransmission and elevated β-amyloid levels [33] . APOE can contribute to reduced neurotransmission as it diminishes glutamate receptor function and synaptic plasticity [34] .
Bioinformatical analysis suggests a central role of APOE in additional synaptic protein changes connected to AD [30] (Fig. 5) . APOE, showing significantly decreased expression in our paradigm, interacts with the mitochondrial import receptor subunit TOMM40 homolog (TOMM40), which causes mitochondrial impairment and neurotoxicity [35] . In reverse, polymorphisms in TOMM40 have an effect on the levels of APOE in the cerebrospinal fluid of non-demented individuals and in the hippocampus of AD patients [36] . Moreover, mutations in the TOMM40 gene are important risk factors for AD [37] .
Several pre-(e.g., synaptotagmin, synaptophysin) and postsynaptic proteins including synaptopodin (SYNPO), which were downregulated in CCH rats, are also known to be downregulated in the brain of AD patients [38] . APOE4 gene expression inactivates the gene transcription of SYNPO and some other proteins involved in synaptic plasticity and synaptic regeneration and remodeling [39] . SYNPO is an actin-associated protein playing a role in modulating actinbased shape determination and essential to the formation of spine apparatuses of neurons, which are involved in synaptic plasticity [40] . The decreased protein level of SYNPO in CCH rats indicates the inhibitory effect of CCH on spine formation and synaptic plasticity. The APOE genotype correlates with synaptosomal-associated protein 25 (SNAP25) depletion in frontotemporal lobar degeneration [41] , which showed decreased expression in CCH rat synapses. Clinical data has already described the reduced level of SNAP25 protein in AD, suggesting its role in impaired neurotransmission [42] , which was also strengthened by the fact that single nucleotide polymorphisms are associated with functional MRI parameters in AD [43] . SNAP25 increases the surface expression of sodium-and chloride-dependent GABA transporter 1 (SLC6A1) [44] . Moreover, SNAP25 and syntaxin 1B (STX1B) are able to interact with each other [45] .
White matter lesion, one of the main pathological consequences of CCH, is also influenced by the APOE genotype [46] . Furthermore, CSF levels of APOE decreased with increasing degree of white matter lesion [47] .
Relationships of Chronic Cerebral Hypoperfusion-Altered Synaptic Proteins with Cognitive Impairment and Dementia
Gap junctional communication and Gap junction alpha-1 protein (GJA1) expression is affected in cerebral ischemia [48] and in different stages of AD [49] . Protein kinase C-induced ubiquitylation of GJA1 is partly mediated by the mitogenactivated protein kinase pathway [50] . GJA1, and specifically its C-terminal domain, is required for optimal LFA-1-mediated Ras-related protein Rap-1A (RAP1) activation and spreading [51] . GJA1 directly regulates excitatory amino acid transporter 2 (SLC1A2) expression and function and modulates the activity of intracellular signal molecules, which in turn leads to its downregulation [52] . SLC1A2 activity is downregulated in the AD brain [53] , and shows a decreased protein level in CCH rats, suggesting decreased degree of glutamate removal from the synaptic cleft. The decreasing SLC1A2 glutamate transporter and ATP1A2 ATPase are part of the same presynaptic macromolecular complex and operate as a functional unit to remove released glutamate from the synaptic cleft [54] . The reduced glutamate reuptake in CCH rats suggests decreased GABA synthesis in the presynaptic region under hypometabolism. ATP1A1 is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled to the exchange of sodium and potassium ions across the plasma membrane, creating their electrochemical gradient to provide energy for active transport of various nutrients. The CCH-induced decreased ATPA1 level indicates downregulated synaptic transport during brain hypometabolism.
Mitogen-activated protein kinase kinase 1 (MAP2K1) has an important role in neuron differentiation and projection [55] . The activity of MAPK signaling is markedly increased in AD brains [56] . The carbohydrate metabolism-related proteins showed increased protein level in CCH rats. Among them, the glucose transport regulator astrocytic phosphoprotein PEA-15 (PEA-15) protein may play a protective role in AD [57] and is able to bind to MAP2K1. MAP2K1 phosphorylation drives cytoplasmic accumulation of heterogeneous nuclear ribonucleoprotein K (HNRPK or HNRNPK) synaptic transmission and spine development regulator protein [58] , whose expression pattern is also correlated with AD progression [59] . ATP-dependent RNA helicase DDX1 (DDX1) could interact with HNRPK which is known to be involved in the regulation of transcription, translation, nuclear transport, and signal transduction [60] .
Serotransferrin (TF) glycosylation [61] and aggregation [62] may play an important role in the pathophysiology of AD and also modulate the homeostasis of full-length APP [63] . Secretory carrier-associated membrane protein 1 (SCAMP1) and AP2-associated protein kinase 1 (AAK1) decreases the TF uptake by endocytosis, suggesting their role in endocytosis via a mechanism which may involve the recruitment of clathrin coats to the plasma membrane and the transGolgi network [64, 65] . Therefore, a decreasing level of SCAMP1 is consistent with increased TF expression in CCH synapse.
Chronic Cerebral Hypoperfusion Inflammatory Effects
In the present study, several CCH-induced synaptic protein changes have a strong relationship with microglia activation and/or astrocytosis (Fig. 5) . Among them, GJA1, SLCA2, and leukocyte surface antigen CD47 (CD47) showed decreased, while APOE, MAP2K1, TF, and PEA-15 showed increased expression in CCH rats. Interestingly, downregulation or absence of GJA1 reduced neuronal loss, capillary fragmentation, astrocytosis, and microglia activation [66] , while reactive astrogliosis increases GJA1 expression [67, 68] . Moreover, brain microgliosis and astrogliosis are also affected in APOE transgenic mice [69] and the absence of APOE dramatically reduced amyloid deposition and the resulting astrogliosis and microgliosis [70] . APOE co-localizes with β-amyloid in basement membrane drainage pathways in the walls of arteries. Furthermore, the attachment of ApoE4/β-amyloid complexes to basement membrane laminin is significantly weaker than ApoE3/β-amyloid complexes [71] . Several previous reports suggest the hypothesis that impaired APOE4 function modulates β-amyloid-induced effects on inflammatory receptor signaling, including amplification of detrimental (toll-like receptor 4-p38α) and suppression of beneficial (IL-4R-nuclear receptor) pathways [72] .
Conclusion
Cerebrovascular pathology is a major risk factor for cognitive dysfunction in the elderly, both on its own, and as a co-morbid pathology [73] . CCH is associated with altered levels of a number of synaptic proteins in the cerebral cortex. Synaptic metabolism and GABA shunt-related proteins are the major functional classes of proteins with increased expression, while neurotransmission and synaptic assembly-related proteins showed the largest decreased protein levels. Bioinformatical analyses of the CCH-altered proteins suggest an important role of APOE in mediating the synaptic effect of CCH. APOE showed an increasing synaptic level under CCH, which was also confirmed with WB. Our identified synaptic protein changes preceding the onset of AD in the CCH model suggest their potential role in the progression of AD.
